<?xml version="1.0" encoding="UTF-8"?>
<ref id="B381-viruses-12-00110">
 <label>381.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mercorelli</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Luganini</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Celegato</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Palu</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Gribaudo</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Loregian</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein</article-title>
  <source>Antivir. Res.</source>
  <year>2018</year>
  <volume>150</volume>
  <fpage>130</fpage>
  <lpage>136</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.12.014</pub-id>
  <pub-id pub-id-type="pmid">29274844</pub-id>
 </element-citation>
</ref>
